| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 3,108,000 | 2,732,000 | 2,390,000 | 2,813,000 | | Cost of Revenue | 2,807,000 | 2,532,000 | 2,360,000 | 2,718,000 | | | Gross Profit | 301,000 | 200,000 | 30,000 | 95,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 131,000 | 124,000 | 96,000 | 119,000 | | Non Recurring | 24,000 | 26,000 | 54,000 | 868,000 | | Others | 5,000 | 6,000 | 5,000 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 141,000 | 44,000 | (125,000) | (892,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,000) |
-
| 33,000 |
-
| | Earnings Before Interest And Taxes | 8,000 | 49,000 | (93,000) | (898,000) | | Interest Expense | (82,000) | 41,000 | 41,000 | 48,000 | | Income Before Tax | 90,000 | 8,000 | (134,000) | (946,000) | | Income Tax Expense | 28,000 | 14,000 | (5,000) |
-
| | Minority Interest |
-
|
-
|
-
| (3,000) | | | | Net Income From Continuing Ops | 92,000 | (6,000) | (129,000) | (946,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 49,000 | (6,000) | (129,000) | (946,000) | | Preferred Stock And Other Adjustments | 7,000 | (5,000) | (2,000) |
-
| | | Net Income Applicable To Common Shares | $56,000 | ($11,000) | ($131,000) | ($946,000) |
|
1.00% Nasdaq 
0.12 (0.51%) 
Income Statement
